Lupin's shares increased by 21.51% over the past year. However, year-to-date (YTD), the stock has decreased by 14.21%. Over the last six mo...

Tata Power's arm Tata Power Renewable Energy has signed a memorandum of understanding (MoU) with the government of Andhra Pradesh to collab...

Biocon share price: Shares of Biocon Ltd rose 3% after Biocon Pharma received FDA approvals for cancer drugs Lenalidomide and Dasatinib, en...

Ami Organics recorded robust growth in the December 2024 quarter. While its revenue increased by 65% year-on-year, adjusted PAT surged by 1...

Leading private lender Axis Bank's standalone net profit rose 4% year-on-year to Rs 6,071 crore in the October-December 2023 period. Net in...

Last week both Nifty and to some extent even mid-cap indices saw some correction. But mid-caps are still a part of the ongoing party on the...

In the last five years many segments of the chemical and specialty chemical sector had been coming into focus. They stay in the limelight f...

While nifty last week witnessed minor corrective movement, the overall trend is still bullish and so are the risk levels. In such times, it...

"Our strategy for India in pharmaceuticals is to continue to make significant investments, we believe that India is a growing market with a...

BPCL board has approved buying out Oman Oil Company's stake in the Bina refinery project in Madhya Pradesh on mutually agreeable terms.

Rivaroxaban is an anticoagulant medication used to treat and prevent blood clots. The medication is currently sold by Bayer under the brand...

Rivaroxaban tablets are indicated for multiple conditions, including reduction of risk of stroke and systemic embolism in patients with non...

Natco and Alembic, however, were directed to undertake that during the life of the respective patent, they will not export the respective p...

Bayer had approached court in 2016 to stop Alembic Pharmaceuticals from exporting its generic of the German company's blood thinner brand '...

In India, Bayer sells the product through its equal stake JV Bayer Zydus, formed with Ahmedabad-based Zydus Cadila.

MNCs are using such information to sue generic firms even at a stage when their marketing approval is still pending or during the few month...

Cipla said as per the law, it is not mandatory to carry out Phase III trials in India for each and every new drug.